PubMed HealthSearch

PubMed · 7653981

Sample size estimation for clinicians.

Abstract

The purpose of this paper is to describe the importance of an adequate sample size in clinical research and to enable clinicians to estimate their own sample size requirements for the more common types of studies (comparison of two means or two proportions). Four pieces of information are required to determine sample size: the desired level of statistical power, the level of statistical significance, the variability of the data, and the smallest difference between the study groups that is considered to be of clinical significance. Worked examples from the literature are used to illustrate how clinicians may easily do their own sample size calculations using published tables or available computer software, or both. The consideration of sample size and power during the planning stages of clinical research is crucial to the subsequent interpretation of study results, especially if the study is negative, and yet this point is often neglected in the medical literature. Attention to these simple guidelines will help ensure that research results lead to valid conclusions.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C P Archibald, H P Lee. 1995. Sample size estimation for clinicians.. https://pubmed.ncbi.nlm.nih.gov/7653981/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Usefulness of statistic experimental designs in enzymology: example with recombinant hCYP3A4 and 1A2.

First, the effects of 10 incubation factors were screened altogether on nifedipine dehydrogenase (NIF) and methoxyresorufin O-deethylase (MROD) activities catalyzed by recombinant human CYP3A4 and 1A2, respectively. Using a statistic experimental design, only 36 assays were needed to be exhaustive. Eight factors influenced CYP3A4-mediated NIF activity: buffer type, pH, temperature, Mg/EDTA, cytochrome b5, NADPH-P450 reductase, NADH, and solvent. Two factors had no significant effect: total ionic concentration and catalase/reduced glutathione. Six factors influenced CYP1A2-mediated MROD rates: buffer type, pH, temperature, Mg/EDTA, NADH, and glycerol. Four factors had no significant effect: total ionic concentration, cytochrome b5, reductase, and NAD+. Secondly, the combined effects of ionic strength and Mg concentration on NIF/CYP3A4 were studied and easily modeled using another statistic experimental design. The effect of Mg was strong at a constant ionic strength of 100 mM and negligible at a constant ionic strength of 500 mM. Thirdly, the effects of influencing factors and their interactions on MROD/CYP1A2 were modeled after 40 assays using a third statistic experimental design. Later experiments confirmed the predictivity of the models and the efficiency of optimized conditions. This approach can be applied to other biochemistry areas.

Biometry